Identification of Systemic Drug Targets for Anti-cavernous Fibrosis in the Treatment of Erectile Dysfunction, Guided by Genome-Wide Mendelian Randomization
The treatment of erectile dysfunction (ED) remains a significant challenge. Mendelian randomization (MR) is being increasingly utilized to identify novel therapeutic targets. In this study, we carried out a genome-wide MR analysis on druggable targets with the aim of pinpointing latent therapeutic a...
Saved in:
| Main Authors: | Zilong Chen, Quan Wang, Lianqin Zhang, Junfeng Qiu, Yangling Zeng, Hao Kuang, Chunxiu Chen, Zhiming Hong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-03-01
|
| Series: | American Journal of Men's Health |
| Online Access: | https://doi.org/10.1177/15579883251323187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem cell therapy for erectile dysfunction of cavernous nerve injury rats: a systematic review and meta-analysis.
by: Haitao Shan, et al.
Published: (2015-01-01) -
Erectile dysfunction: A GP's guide to clinical assessment
by: P.J. Harden
Published: (2003-10-01) -
Erectile dysfunction
by: Haley Smith
Published: (2015-03-01) -
Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
by: Wei Wang, et al.
Published: (2025-07-01) -
Association between prescription medication and erectile dysfunction: results from NHANES dataset and mendelian randomization study
by: Jian Cai, et al.
Published: (2025-12-01)